Food and Drug Administration v. Alliance for Hippocratic Medicine: How Conscience Protections Preserved Mifepristone Access
Hastings Center Report · 2025
DOI: 10.1002/hast.4974 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hastings Center Report, 2025. Verfasst von Rebecca Dresser. Hauptthemen laut MEDLINE: Conscience, Mifepristone, Abortifacient Agents, Steroidal, Conscientious Refusal to Treat. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
People in the bioethics field generally agree that clinicians should have reasonable freedom to practice according to their moral and religious convictions. But this general position leaves room for debate over how much freedom objecting clinicians ought to have. Some commentators contend that exemptions from criminal, civil, and professional consequences for conscientious refusals to provide care impose too many burdens on patients, colleagues, and health care institutions. Others argue that existing protections are insufficient, failing to cover clinicians who are moved to provide legally permitted care to patients in the face of institutional and employment constraints on doing so. A 2024 United States Supreme Court ruling adds another element to the debate, showing how conscience‐law protections can defeat legal efforts to limit access to contested treatments .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Dresser, R. (2025). Food and Drug Administration v. Alliance for Hippocratic Medicine: How Conscience Protections Preserved Mifepristone Access. Hastings Center Report. https://doi.org/10.1002/hast.4974
Vancouver
Dresser R. Food and Drug Administration v. Alliance for Hippocratic Medicine: How Conscience Protections Preserved Mifepristone Access. Hastings Center Report. 2025. doi:10.1002/hast.4974
BibTeX
@article{Dresser2025,
author = {Dresser, Rebecca},
title = {Food and Drug Administration v. Alliance for Hippocratic Medicine: How Conscience Protections Preserved Mifepristone Access},
journal = {Hastings Center Report},
year = {2025},
doi = {10.1002/hast.4974}
}
EUVIMED